Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- NA
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
- Status
- UNKNOWN
- Phase
- NA
Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
- Status
- COMPLETED
- Phase
- PHASE1
Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
- Status
- COMPLETED
- Phase
- NA
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- NA
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- NA
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
- Status
- COMPLETED
- Phase
- N/A
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
- Status
- COMPLETED
- Phase
- N/A
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bortezomib in Treating Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2